Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Brancico XL
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Brancico XL 300mg tablets
0402010ABBLAAAX
|
Brancico XL | Quetiapine | Central Nervous System | 7,786 |
|
Brancico XL 50mg tablets
0402010ABBLADAV
|
Brancico XL | Quetiapine | Central Nervous System | 7,225 |
|
Brancico XL 400mg tablets
0402010ABBLAEAY
|
Brancico XL | Quetiapine | Central Nervous System | 5,328 |
|
Brancico XL 200mg tablets
0402010ABBLABAW
|
Brancico XL | Quetiapine | Central Nervous System | 5,125 |
|
Brancico XL 150mg tablets
0402010ABBLACBA
|
Brancico XL | Quetiapine | Central Nervous System | 3,657 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.